Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma

References

• VerslypeCRosmorducORougierPHepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201223Suppl 7vii41vii4822997453
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the LiverEuropean Organisation for Research and Treatment of CancerEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol201256490894322424438
   PubMed Web of Science ®Google Scholar
• SinghSSinghPPRobertsLRSanchezWChemopreventive strategies in hepatocellular carcinomaNat Rev20141114554
   Google Scholar
• GomaaA-IHepatocellular carcinoma: epidemiology, risk factors and pathogenesisWorld J Gastroenterol20081427430018666317
   PubMed Web of Science ®Google Scholar
• BruixJShermanMManagement of hepatocellular carcinoma: an updateHepatology20115331020102221374666
   PubMed Web of Science ®Google Scholar
• GutierrezJAGishRGEfficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel small moleculesTransl Cancer Res20132646047126504748
   PubMedGoogle Scholar
• ToppZZSigalDSBeyond chemotherapy: systemic treatment options for hepatocellular carcinomaTransl Cancer Res201326482491
   Google Scholar
• WilhelmSMCarterCTangLBAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesisCancer Res200464197099710915466206
   PubMed Web of Science ®Google Scholar
• ChangYSAdnaneJTrailPASorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft modelsCancer Chemother Pharmacol200759556157417160391
   PubMed Web of Science ®Google Scholar
• LlovetJMRicciSMazzaferroVSorafenib in advanced hepatocellular carcinomaN Engl J Med2008359437839018650514
   PubMed Web of Science ®Google Scholar
• GilletJPAndersenJBMadiganJPA gene expression signature associated with overall survival in patients with hepatocellular carcinoma suggests a new treatment strategyMol Pharmacol201689226327226668215
   PubMedGoogle Scholar
• ParveenSMisraRSahooSKNanoparticles: a boon to drug delivery, therapeutics, diagnostics and imagingNanomedicine20128214716621703993
   PubMed Web of Science ®Google Scholar
• LingDXiaHParkWpH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinomaACS Nano2014888027803925093274
   PubMed Web of Science ®Google Scholar
• YuanYFengGQinWTangBZLiuBTargeted and image-guided photodynamic cancer therapy based on organic nanoparticles with aggregation-induced emission characteristicsChem Commun (Camb)201450638757876024967727
   PubMedGoogle Scholar
• DingDLiuJFengGLiKHuYLiuBBright far-red/near-infrared conjugated polymer nanoparticles for in vivo bioimagingSmall20139183093310223625815
   PubMedGoogle Scholar
• VarshosazJFarzanMNanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinomaWorld J Gastroenterol20152142120221204126576089
   PubMed Web of Science ®Google Scholar
• YeLYChenWBaiXLHypoxia-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma induces an immunosuppressive tumor microenvironment to promote metastasisCancer Res201676481883026837767
   PubMed Web of Science ®Google Scholar
• FerraraNHouckKJakemanLLeungDWMolecular and biological properties of the vascular endothelial growth factor family of proteinsEndocrine Rev199213118321372863
   PubMed Web of Science ®Google Scholar
• CarmelietPMechanisms of angiogenesis and arteriogenesisNat Med20006438939510742145
   PubMed Web of Science ®Google Scholar
• CompagniAWilgenbusPImpagnatielloMACottenMChristoforiGFibroblast growth factors are required for efficient tumor angiogenesisCancer Res200060247163716911156426
   PubMed Web of Science ®Google Scholar
• McDougallSRAndersonARChaplainMAMathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategiesJ Theor Biol2006241356458916487543
   PubMed Web of Science ®Google Scholar
• MaedaHThe enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targetingAdv Enzyme Regul200141118920711384745
   PubMedGoogle Scholar
• KaminskasLMMcLeodVMKellyBDA comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systemsNanomedicine20128110311121704192
   PubMed Web of Science ®Google Scholar
• GerlowskiLEJainRKMicrovascular permeability of normal and neoplastic tissuesMicrovasc Res19863132883052423854
   PubMed Web of Science ®Google Scholar
• MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancsCancer Res19864612 Pt 1638763922946403
   PubMed Web of Science ®Google Scholar
• DanhierFFeronOPreatVTo exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug deliveryJ Control Release2010148213514620797419
   PubMed Web of Science ®Google Scholar
• NarangASVariaSRole of tumor vascular architecture in drug deliveryAdv Drug Deliv Rev201163864065821514334
   PubMedGoogle Scholar
• SemelaDDufourJFAngiogenesis and hepatocellular carcinomaJ Hepatol200441586488015519663
   PubMed Web of Science ®Google Scholar
• WilhelmSTavaresAJDaiQAnalysis of nanoparticle delivery to tumoursNat Rev Mater2016116014
   Web of Science ®Google Scholar
• BlancoEShenHFerrariMPrinciples of nanoparticle design for overcoming biological barriers to drug deliveryNat Biotech2015339941951
   PubMed Web of Science ®Google Scholar
• VenturoliDRippeBFicoll and dextran vs globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformabilityAm J Physiol20052884F605F613
   Google Scholar
• ChoiHSLiuWMisraPRenal clearance of quantum dotsNat Biotechnol200725101165117017891134
   PubMed Web of Science ®Google Scholar
• ShubayevVIPisanic IiTRJinSMagnetic nanoparticles for theragnosticsAdv Drug Deliv Rev200961646747719389434
   PubMed Web of Science ®Google Scholar
• KievitFMZhangMCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriersAdv Mater20112336H217H24721842473
   PubMed Web of Science ®Google Scholar
• WarrenACoggerVCAriasIMMcCuskeyRSLe CouteurDGLiver sinusoidal endothelial fenestrations in caveolin-1 knockout miceMicrocirculation2010171323820141598
   PubMedGoogle Scholar
• ChoKWangXNieSChenZGShinDMTherapeutic nanoparticles for drug delivery in cancerClin Cancer Res20081451310131618316549
   PubMed Web of Science ®Google Scholar
• ByrneJDBetancourtTBrannon-PeppasLActive targeting schemes for nanoparticle systems in cancer therapeuticsAdv Drug Deliv Rev200860151615162618840489
   PubMed Web of Science ®Google Scholar
• BriggerIDubernetCCouvreurPNanoparticles in cancer therapy and diagnosisAdv Drug Deliv Rev200254563165112204596
   PubMed Web of Science ®Google Scholar
• StylianopoulosTJainRKDesign considerations for nanotherapeutics in oncologyNanomedicine20151181893190726282377
   PubMed Web of Science ®Google Scholar
• GaoHChengTLiuJSelf-regulated multifunctional collaboration of targeted nanocarriers for enhanced tumor therapyBiomacromolecules201415103634364225308336
   PubMedGoogle Scholar
• GaurUSahooSKDeTKGhoshPCMaitraAGhoshPKBiodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial systemInt J Pharm20002021–211010915921
   PubMed Web of Science ®Google Scholar
• AdamsMLLavasanifarAKwonGSAmphiphilic block copolymers for drug deliveryJ Pharm Sci20039271343135512820139
   PubMed Web of Science ®Google Scholar
• DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discov200879771782
   PubMed Web of Science ®Google Scholar
• UpponiJRTorchilinVPPassive vs active targeting: an update of the EPR role in drug delivery to tumorsAlonsoJMGarcia-FuentesMNano-Oncologicals: New Targeting and Delivery ApproachesChamSpringer International Publishing2014345
   Google Scholar
• YameenBChoiWIVilosCSwamiAShiJFarokhzadOCInsight into nanoparticle cellular uptake and intracellular targetingJ Control Release201419048549924984011
   PubMed Web of Science ®Google Scholar
• ZhongYMengFDengCZhongZLigand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapyBiomacromolecules20141561955196924798476
   PubMed Web of Science ®Google Scholar
• JainKKesharwaniPGuptaUJainNKA review of glycosylated carriers for drug deliveryBiomaterials201233164166418622398205
   PubMed Web of Science ®Google Scholar
• BaenzigerJUMaynardYHuman hepatic lectin. Physiochemical properties and specificityJ Biol Chem198025510460746137372599
   PubMed Web of Science ®Google Scholar
• D’SouzaAADevarajanPVAsialoglycoprotein receptor mediated hepatocyte targeting – strategies and applicationsJ Control Release201520312613925701309
   PubMed Web of Science ®Google Scholar
• ZhangXNgHLLuADrug delivery system targeting advanced hepatocellular carcinoma: current and futureNanomedicine201612485386926772424
   PubMed Web of Science ®Google Scholar
• WangBHuQWanTPorous lactose-modified chitosan scaffold for liver tissue engineering: influence of galactose moieties on cell attachment and mechanical stabilityInt J Polym Sci201620168
   Google Scholar
• LiYHuangGDiakurJWiebeLITargeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug developmentCurr Drug Deliv20085429930218855599
   PubMedGoogle Scholar
• ZhangXGuoSFanRDual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cellsBiomaterials201233297103711422796159
   PubMed Web of Science ®Google Scholar
• FrischBCarriereMLargeauCA new triantennary galactose-targeted PEGylated gene carrier, characterization of its complex with DNA, and transfection of hepatoma cellsBioconjug Chem200415475476415264862
   PubMedGoogle Scholar
• LiuHWangHXuYLactobionic acid-modified dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of human hepatocellular carcinomaACS Appl Mater Interfaces2014696944695324712914
   PubMedGoogle Scholar
• RajasekaranDSrivastavaJEbeidKCombination of nanoparticle-delivered siRNA for astrocyte elevated gene-1 (AEG-1) and all-trans retinoic acid (ATRA): an effective therapeutic strategy for hepatocellular carcinoma (HCC)Bioconjug Chem20152681651166126079152
   PubMedGoogle Scholar
• PanQLvYWilliamsGRLactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systemsCarbohydr Polym201615181282027474628
   PubMed Web of Science ®Google Scholar
• WuDQLuBChangCGalactosylated fluorescent labeled micelles as a liver targeting drug carrierBiomaterials20093071363137119100617
   PubMedGoogle Scholar
• WeiWYueZGQuJBYueHSuZGMaGHGalactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: an in vitro evaluationNanomedicine (Lond)20105458959620528454
   PubMed Web of Science ®Google Scholar
• YangRMengFMaSHuangFLiuHZhongZGalactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(epsilon-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxelBiomacromolecules20111283047305521726090
   PubMedGoogle Scholar
• ZhongYYangWSunHLigand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cellsBiomacromolecules201314103723373023998942
   PubMed Web of Science ®Google Scholar
• ChenWZouYMengFGlyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugsBiomacromolecules201415390090724460130
   PubMed Web of Science ®Google Scholar
• ZouYSongYYangWMengFLiuHZhongZGalactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in miceJ Control Release201419315416124852094
   PubMed Web of Science ®Google Scholar
• DuanCGaoJZhangDGalactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridoninBiomacromolecules201112124335434322077387
   PubMed Web of Science ®Google Scholar
• VillaRCerroniBViganoLTargeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cellsColloids Surf B Biointerfaces201311043444223759384
   PubMed Web of Science ®Google Scholar
• LuoZHuYCaiKIntracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificityBiomaterials201435277951796224930850
   PubMed Web of Science ®Google Scholar
• XuZChenLGuWThe performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinomaBiomaterials200930222623218851881
   PubMed Web of Science ®Google Scholar
• KimTHParkIKNahJWChoiYJChoCSGalactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrierBiomaterials200425173783379215020154
   PubMed Web of Science ®Google Scholar
• KimEMJeongHJParkIKAsialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): in vitro and in vivo studiesJ Control Release20051082–355756716253376
   PubMed Web of Science ®Google Scholar
• YangYZhangZChenLGuWLiYGalactosylated poly(2-(2-aminoethyoxy)ethoxy)phosphazene/DNA complex nanoparticles: in vitro and in vivo evaluation for gene deliveryBiomacromolecules201011492793320302354
   PubMedGoogle Scholar
• MaPLiuSHuangYChenXZhangLJingXLactose mediated liver-targeting effect observed by ex vivo imaging technologyBiomaterials20103192646265420036420
   PubMed Web of Science ®Google Scholar
• XueWJFengYWangFAsialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinomaSci Rep201662214926915683
   PubMedGoogle Scholar
• LiangHFChenSCChenMCLeePWChenCTSungHWPaclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cellsBioconjug Chem200617229129916536458
   PubMed Web of Science ®Google Scholar
• ZhuDTaoWZhangHDocetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancerActa Biomater20163014415426602819
   PubMed Web of Science ®Google Scholar
• ThapaBKumarPZengHNarainRAsialoglycoprotein receptor-mediated gene delivery to hepatocytes using galactosylated polymersBiomacromolecules20151693008302026258607
   PubMedGoogle Scholar
• QuanSWangYZhouAKumarPNarainRGalactose-based thermosensitive nanogels for targeted drug delivery of iodoazomycin arabinofuranoside (IAZA) for theranostic management of hypoxic hepatocellular carcinomaBiomacromolecules20151671978198625996799
   PubMedGoogle Scholar
• LeeYCTownsendRRHardyMRBinding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural featuresJ Biol Chem198325811992026848494
   PubMed Web of Science ®Google Scholar
• ManagitCKawakamiSYamashitaFHashidaMEffect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomesJ Pharm Sci200594102266227516136555
   PubMed Web of Science ®Google Scholar
• ManagitCKawakamiSYamashitaFHashidaMUptake characteristics of galactosylated emulsion by HepG2 hepatoma cellsInt J Pharm20053011–225526116076536
   PubMed Web of Science ®Google Scholar
• FuFWuYZhuJWenSShenMShiXMultifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacerACS Appl Mater Interfaces2014618164161642525185074
   PubMed Web of Science ®Google Scholar
• CraparoEFSardoCSerioRGalactosylated polymeric carriers for liver targeting of sorafenibInt J Pharm20144661–217218024607205
   PubMedGoogle Scholar
• OhEJParkKKimKSTarget specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivativesJ Control Release2010141121219758573
   PubMed Web of Science ®Google Scholar
• RossoFQuagliarielloVTortoraCDi LazzaroABarbarisiAIaffaioliRVCross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft modelJ Mater Sci201324614731481
   Google Scholar
• ChoiKYMinKHYoonHYPEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivoBiomaterials20113271880188921159377
   PubMed Web of Science ®Google Scholar
• RaoNVYoonHYHanHSRecent developments in hyaluronic acid-based nanomedicine for targeted cancer treatmentExp Opin Drug Deliv2016132239252
   PubMed Web of Science ®Google Scholar
• XiaoBHanMKViennoisEHyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapyNanoscale2015742177451775526455329
   PubMed Web of Science ®Google Scholar
• YangRMFuCPLiNNGlycosaminoglycan-targeted iron oxide nanoparticles for magnetic resonance imaging of liver carcinomaMater Sci Eng C201445556563
   PubMed Web of Science ®Google Scholar
• KumarCSRajaMDSundarDSGover AntonirajMRuckmaniKHyaluronic acid co-functionalized gold nanoparticle complex for the targeted delivery of metformin in the treatment of liver cancer (HepG2 cells)Carbohydr Polym2015128637426005140
   PubMed Web of Science ®Google Scholar
• OpanasopitPApirakaramwongANgawhirunpatTRojanarataTRuktanonchaiUDevelopment and characterization of pectinate micro/nanoparticles for gene deliveryAAPS PharmSciTech200891677418446463
   PubMedGoogle Scholar
• ChittasuphoCJaturanpinyoMMangmoolSPectin nanoparticle enhances cytotoxicity of methotrexate against HepG2 cellsDrug Deliv20132011923216416
   PubMed Web of Science ®Google Scholar
• YuCYWangYMLiNMIn vitro and in vivo evaluation of pectin-based nanoparticles for hepatocellular carcinoma drug chemotherapyMol Pharm201411263864424383625
   PubMed Web of Science ®Google Scholar
• KaneoYTanakaTNakanoTYamaguchiYEvidence for receptor-mediated hepatic uptake of pullulan in ratsJ Control Release200170336537311182206
   PubMed Web of Science ®Google Scholar
• ZhangCAnTWangDStepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(beta-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinomaJ Control Release201622619320426896737
   PubMed Web of Science ®Google Scholar
• LeamonCPLowPSFolate-mediated targeting: from diagnostics to drug and gene deliveryDrug Discov Today200161445111165172
   PubMed Web of Science ®Google Scholar
• LucockMFolic acid: nutritional biochemistry, molecular biology, and role in disease processesMol Genet Metab2000711–212113811001804
   PubMed Web of Science ®Google Scholar
• KamenBACapdevilaAReceptor-mediated folate accumulation is regulated by the cellular folate contentProc Natl Acad Sci U S A19868316598359873461471
   PubMedGoogle Scholar
• TengchaisriTChawengkirttikulRRachaphaewNReutrakulVSangsuwanRSirisinhaSAntitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamstersCancer Lett1998133216917510072166
   PubMed Web of Science ®Google Scholar
• PhillipsPADudejaVMcCarrollJATriptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70Cancer Res200767199407941617909050
   PubMedGoogle Scholar
• AlsaiedOASangwanVBanerjeeSSorafenib and triptolide as combination therapy for hepatocellular carcinomaSurgery2014156227027924953273
   PubMedGoogle Scholar
• NiuCSunQZhouJChengDHongGFolate-functionalized polymeric micelles based on biodegradable PEG-PDLLA as a hepatic carcinoma-targeting delivery systemAsian Pacific J Cancer Prev201112819951999
   PubMedGoogle Scholar
• XuZZhangZChenYChenLLinLLiYThe characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma modelBiomaterials201031591692219846217
   PubMed Web of Science ®Google Scholar
• LeiXYZhongMFengLFZhuBYTangSSLiaoDFsiRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugsClin Exp Pharm Physiol2007345–6450456
   Google Scholar
• CaoNChengDZouSAiHGaoJShuaiXThe synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cellsBiomaterials20113282222223221186059
   PubMed Web of Science ®Google Scholar
• HuBGLiuLPChenGGTherapeutic efficacy of improved alpha-fetoprotein promoter-mediated tBid delivered by folate-PEI600-cyclodextrin nanopolymer vector in hepatocellular carcinomaExp Cell Res2014324218319124726886
   PubMedGoogle Scholar
• FanLLiFZhangHCo-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistanceBiomaterials201031215634564220430433
   PubMed Web of Science ®Google Scholar
• TangZYHepatocellular carcinoma – cause, treatment and metastasisWorld J Gastroenterol20017444545411819809
   PubMed Web of Science ®Google Scholar
• YeQHQinLXForguesMPredicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learningNat Med20039441642312640447
   PubMed Web of Science ®Google Scholar
• UkaKAikataHTakakiSClinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinomaWorld J Gastroenterol200713341442017230611
   PubMed Web of Science ®Google Scholar
• ZhangYZhangHWuWFolate-targeted paclitaxel-conjugated polymeric micelles inhibits pulmonary metastatic hepatoma in experimental murine H22 metastasis modelsInt J Nanomedicine201492019203024790440
   PubMed Web of Science ®Google Scholar
• WangWChengDGongFMiaoXShuaiXDesign of multifunctional micelle for tumor-targeted intracellular drug release and fluorescent imagingAdv Mater201224111512022143956
   PubMed Web of Science ®Google Scholar
• LiLTongRLiMKohaneDSSelf-assembled gemcitabine – gadolinium nanoparticles for magnetic resonance imaging and cancer therapyActa Biomater201633343926826531
   PubMedGoogle Scholar
• ChenYLiMHongYLamJWZhengQTangBZDual-modal MRI contrast agent with aggregation-induced emission characteristic for liver specific imaging with long circulation lifetimeACS Appl Mater Interfaces2014613107831079124942209
   PubMed Web of Science ®Google Scholar
• MaengJHLeeDHJungKHMultifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancerBiomaterials201031184995500620347138
   PubMed Web of Science ®Google Scholar
• LiXLiHYiWChenJLiangBAcid-triggered core cross-linked nanomicelles for targeted drug delivery and magnetic resonance imaging in liver cancer cellsInt J Nanomedicine201383019303123976852
   PubMed Web of Science ®Google Scholar
• LiYJDongMKongFMZhouJPFolate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeuticsInt J Pharm20154891–2839025888801
   PubMedGoogle Scholar
• ViotaJLCarazoAMunoz-GamezJAFunctionalized magnetic nanoparticles as vehicles for the delivery of the antitumor drug gemcitabine to tumor cells. Physicochemical in vitro evaluationMater Sci Eng C201333311831192
   PubMed Web of Science ®Google Scholar
• GuoYWangJZhangLTheranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinomaHepatology20166341240125526680504
   PubMed Web of Science ®Google Scholar
• Russell-JonesGMcTavishKMcEwanJRiceJNowotnikDVitamin-mediated targeting as a potential mechanism to increase drug uptake by tumoursJ Inorg Biochem200498101625163315458825
   PubMed Web of Science ®Google Scholar
• ChenSZhaoXChenJKuznetsovaLWongSSOjimaIMechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug releaseBioconjug Chem201021597998720429547
   PubMed Web of Science ®Google Scholar
• MishraPRJainNKBiotinylated methotrexate loaded erythrocytes for enhanced liver uptake. “A study on the rat”Int J Pharm2002231214515311755267
   PubMedGoogle Scholar
• NaKBum LeeTParkK-HShinE-KLeeY-BChoiH-KSelf-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery systemEur J Pharm Sci200318216517312594010
   PubMed Web of Science ®Google Scholar
• HongYLamJWYTangBZAggregation-induced emission: phenomenon, mechanism and applicationsChem Commun20092943324353
   Google Scholar
• HongYLamJWYTangBZAggregation-induced emissionChem Soc Rev201140115361538821799992
   PubMed Web of Science ®Google Scholar
• LiMLamJWYMahtabFBiotin-decorated fluorescent silica nanoparticles with aggregation-induced emission characteristics: fabrication, cytotoxicity and biological applicationsJ Mater Chem B201315676684
   PubMed Web of Science ®Google Scholar
• SchugTTBerryDCShawNSTravisSNNoyNOpposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptorsCell2007129472373317512406
   PubMed Web of Science ®Google Scholar
• JinushiMTakeharaTTatsumiTExpression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acidInt J Cancer2003104335436112569559
   PubMed Web of Science ®Google Scholar
• SanoKTakayamaTMurakamiKSaikiIMakuuchiMOverexpression of retinoic acid receptor alpha in hepatocellular carcinomaClin Cancer Res2003910 Pt 13679368314506158
   PubMedGoogle Scholar
• VarshosazJHassanzadehFSadeghiHGhelich KhanZRostamiMRetinoic acid decorated albumin-chitosan nanoparticles for targeted delivery of doxorubicin hydrochloride in hepatocellular carcinomaJ Nanomater20132013112
   Web of Science ®Google Scholar
• MichelVYuanZRamsubirSBakovicMCholine transport for phospholipid synthesisExp Biol Med (Maywood)2006231549050416636297
   PubMed Web of Science ®Google Scholar
• AirleyREMobasheriAHypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeuticsChemotherapy200753423325617595539
   PubMed Web of Science ®Google Scholar
• KimJWDangCVCancer’s molecular sweet tooth and the Warburg effectCancer Res200666188927893016982728
   PubMed Web of Science ®Google Scholar
• WoodISTrayhurnPGlucose transporters (GLUT and SGLT): expanded families of sugar transport proteinsBr J Nutr20038913912568659
   PubMed Web of Science ®Google Scholar
• RumseySCKwonOXuGWBurantCFSimpsonILevineMGlucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acidJ Biol Chem19972723018982189899228080
   PubMed Web of Science ®Google Scholar
• VeraJCRivasCIZhangRHFarberCMGoldeDWHuman HL-60 myeloid leukemia cells transport dehydroascorbic acid via the glucose transporters and accumulate reduced ascorbic acidBlood1994845162816348068952
   PubMed Web of Science ®Google Scholar
• GuoYZhangYLiJCell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma therapyACS Appl Mater Interfaces2015795444545325686400
   PubMedGoogle Scholar
• ArrueboMValladaresMGonzález-FernándezÁAntibody-conjugated nanoparticles for biomedical applicationsJ Nanomater20092009124
   Web of Science ®Google Scholar
• GoodallSJonesMLMahlerSMonoclonal antibody-targeted polymeric nanoparticles for cancer therapy – future prospectsJ Chem Technol Biotechnol201590711691176
   Google Scholar
• HeQLuWSLiuYGuanYSKuangAR131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinomaWorld J Gastroenterol201319479104911024379637
   PubMedGoogle Scholar
• XuJXuHYZhangQHAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinomaMol Cancer Res20075660561417579119
   PubMed Web of Science ®Google Scholar
• JinCQianNZhaoWImproved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab’) (2) for hepatocellular carcinomaBiomacromolecules20101192422243120831277
   PubMed Web of Science ®Google Scholar
• ZhuRZhangCGLiuYCD147 monoclonal antibody mediated by chitosan nanoparticles loaded with alpha-hederin enhances antineoplastic activity and cellular uptake in liver cancer cellsSci Rep201551790426639052
   PubMed Web of Science ®Google Scholar
• LiBWangHZhangDConstruction and characterization of a high-affinity humanized SM5-1 monoclonal antibodyBiochem Biophys Res Commun2007357495195617451647
   PubMedGoogle Scholar
• WangHSongSKouGTreatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndromeCancer Immunol Immunother200756111775178317431617
   PubMed Web of Science ®Google Scholar
• KouGWangSChengCDevelopment of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detectionBiochem Biophys Res Commun2008374219219718621023
   PubMedGoogle Scholar
• MaXHuiHJinYEnhanced immunotherapy of SM5-1 in hepatocellular carcinoma by conjugating with gold nanoparticles and its in vivo bioluminescence tomographic evaluationBiomaterials201687465626897539
   PubMed Web of Science ®Google Scholar
• KouGGaoJWangHPreparation and characterization of paclitaxel-loaded PLGA nanoparticles coated with cationic SM5-1 single-chain antibodyJ Biochem Mol Biol200740573173917927907
   PubMedGoogle Scholar
• GaoJKouGChenHTreatment of hepatocellular carcinoma in mice with PE38KDEL type I mutant-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated with humanized SM5-1 F(ab’) fragmentsMol Cancer Therap20087103399340718852143
   PubMedGoogle Scholar
• KissAWangNJXieJPThorgeirssonSSAnalysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met, TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomasClin Cancer Res199737105910669815784
   PubMed Web of Science ®Google Scholar
• SibiliaMKroismayrRLichtenbergerBMNatarajanAHeckingMHolcmannMThe epidermal growth factor receptor: from development to tumorigenesisDifferentiation200775977078717999740
   PubMed Web of Science ®Google Scholar
• LiuPLiZZhuMPreparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinomaJ Mater Sci2010212551556
   Google Scholar
• WangJLTangGPShenJA gene nanocomplex conjugated with monoclonal antibodies for targeted therapy of hepatocellular carcinomaBiomaterials201233184597460722469295
   PubMed Web of Science ®Google Scholar
• ChenJWuHHanDXieCUsing anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancerCancer Lett2006231216917516399221
   PubMed Web of Science ®Google Scholar
• MathewJHinesJEObafunwaJOBurrAWTooleKBurtADCD44 is expressed in hepatocellular carcinomas showing vascular invasionJ Pathol1996179174798691349
   PubMedGoogle Scholar
• WangLSuWLiuZCD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinomaBiomaterials201233205107511422494888
   PubMed Web of Science ®Google Scholar
• ZhangX-XLiH-DZhaoSThe cell surface GRP78 facilitates the invasion of hepatocellular carcinoma cellsBiomed Res Int2013201318
   Google Scholar
• LiZLiZGlucose regulated protein 78: A critical link between tumor microenvironment and cancer hallmarksBiochim Biophys Acta201218261132222426159
   PubMed Web of Science ®Google Scholar
• ZhaoLLiHShiYNanoparticles inhibit cancer cell invasion and enhance antitumor efficiency by targeted drug delivery via cell surface-related GRP78Int J Nanomedicine20151024525625565817
   PubMed Web of Science ®Google Scholar
• TakahashiHOzturkMWilsonBIn vivo expression of two novel tumor-associated antigens and their use in immunolocalization of human hepatocellular carcinomaHepatology1989946256342538386
   PubMed Web of Science ®Google Scholar
• MoradpourDCompagnonBWilsonBENicolauCWandsJRSpecific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitroHepatology1995225152715377590672
   PubMedGoogle Scholar
• FilmusJSelleckSBGlypicans: proteoglycans with a surpriseJ Clin Invest2001108449750111518720
   PubMed Web of Science ®Google Scholar
• CapurroMWanlessIRShermanMGlypican-3: a novel serum and histochemical marker for hepatocellular carcinomaGastroenterology20031251899712851874
   PubMed Web of Science ®Google Scholar
• IshiguroTSugimotoMKinoshitaYAnti-glypican 3 antibody as a potential antitumor agent for human liver cancerCancer Res200868239832983819047163
   PubMed Web of Science ®Google Scholar
• PhungYGaoWManYGNagataSHoMHigh-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screeningMAbs20124559259922820551
   PubMed Web of Science ®Google Scholar
• NakanoKOritaTNezuJAnti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cellsBiochem Biophys Res Commun2009378227928419022220
   PubMed Web of Science ®Google Scholar
• FengMGaoWWangRTherapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinomaProc Natl Acad Sci U S A201311012E1083E109123471984
   PubMedGoogle Scholar
• HanaokaHNagayaTSatoKGlypican-3 targeted human heavy chain antibody as a drug carrier for hepatocellular carcinoma therapyMol Pharm20151262151215725955255
   PubMedGoogle Scholar
• WangKKievitFMShamJGIron-oxide-based nanovector for tumor targeted siRNA delivery in an orthotopic hepatocellular carcinoma xenograft mouse modelSmall201612447748726641029
   PubMed Web of Science ®Google Scholar
• ZitzmannSEhemannVSchwabMArginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivoCancer Res200262185139514312234975
   PubMed Web of Science ®Google Scholar
• DanhierFLe BretonAPreatVRGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosisMol Pharm20129112961297322967287
   PubMed Web of Science ®Google Scholar
• BellisSLAdvantages of RGD peptides for directing cell association with biomaterialsBiomaterials201132184205421021515168
   PubMed Web of Science ®Google Scholar
• ChenLLiuYWangWLiuKEffect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapyOncol Lett2015101778426170980
   PubMed Web of Science ®Google Scholar
• MarelliUKRechenmacherFSobahiTRMas-MorunoCKesslerHTumor targeting via integrin ligandsFront Oncol2013322224010121
   PubMedGoogle Scholar
• MitraAColemanTBorgmanMNanAGhandehariHLineBRPolymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targetingJ Control Release2006114217518316889865
   PubMed Web of Science ®Google Scholar
• ShenJMGaoFYYinTcRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapyPharmacol Res201370110211523376353
   PubMed Web of Science ®Google Scholar
• SugaharaKNTeesaluTKarmaliPPTissue-penetrating delivery of compounds and nanoparticles into tumorsCancer Cell200916651052019962669
   PubMed Web of Science ®Google Scholar
• ZhuZXieCLiuQThe effect of hydrophilic chain length and iRGD on drug delivery from poly(epsilon-caprolactone)-poly(N-vinylpyrrolidone) nanoparticlesBiomaterials201132359525953521903260
   PubMed Web of Science ®Google Scholar
• MaoXLiuJGongZiRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cellsNanomedicine (Lond)201510172677269526355733
   PubMedGoogle Scholar
• ZhangJHuJChanHFSkibbaMLiangGChenMiRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacyNanomedicine20161251303131126964482
   PubMed Web of Science ®Google Scholar
• WalkerPSReidMEThe Gerbich blood group system: a reviewImmunohematology2010262606520932076
   PubMedGoogle Scholar
• LiZZhaoRWuXIdentification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeuticsFASEB J200519141978198516319141
   PubMed Web of Science ®Google Scholar
• TangHChenXRuiMEffects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumorMol Pharm201411103242325025181533
   PubMedGoogle Scholar
• KlutzKSchaffertDWillhauckMJEpidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter geneMol Ther201119467668521245850
   PubMed Web of Science ®Google Scholar
• LiuMLiZHXuFJAn oligopeptide ligand-mediated therapeutic gene nanocomplex for liver cancer-targeted therapyBiomaterials20123372240225022177837
   PubMed Web of Science ®Google Scholar
• ZhengNWeiWWangZEmerging roles of FGF signaling in hepatocellular carcinomaTransl Cancer Res2016511627226954
   PubMedGoogle Scholar
• MarutaFParkerALFisherKDIdentification of FGF receptor-binding peptides for cancer gene therapyCancer Gene therapy20029654355212032665
   PubMed Web of Science ®Google Scholar
• HuYTangGLiuJFGF receptor-mediated gene delivery using ligands coupled to PEI-beta-CyDJ Biomed Biotechnol2012201298923522570536
   PubMedGoogle Scholar
• LoALinCTWuHCHepatocellular carcinoma cell-specific peptide ligand for targeted drug deliveryMol Cancer Ther20087357958918347144
   PubMed Web of Science ®Google Scholar
• ToitaRMurataMTabataSDevelopment of human hepatocellular carcinoma cell-targeted protein cagesBioconjug Chem20122371494150122621213
   PubMed Web of Science ®Google Scholar
• MoonHLeeJMinJKangSDeveloping genetically engineered encapsulin protein cage nanoparticles as a targeted delivery nanoplatformBiomacromolecules201415103794380125180761
   PubMed Web of Science ®Google Scholar
• OhSKimBJSinghNPLaiHSasakiTSynthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptideCancer Lett20092741333918838215
   PubMed Web of Science ®Google Scholar
• HanLHuangRLiuSHuangSJiangCPeptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumorsMol Pharm2010762156216520857964
   PubMed Web of Science ®Google Scholar
• TrouetADeprez-De CampeneereDDaunorubicin-DNA and doxorubicin-DNA. A review of experimental and clinical dataCancer Chemother Pharmacol1979217779498424
   PubMedGoogle Scholar
• BagalkotVLeeIHYuMKA combined chemoimmunotherapy approach using a plasmid-doxorubicin complexMol Pharm2009631019102819338265
   PubMed Web of Science ®Google Scholar
• HanLHuangRLiJLiuSHuangSJiangCPlasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimerBiomaterials20113241242125220971503
   PubMed Web of Science ®Google Scholar
• FarokhzadOCChengJTeplyBATargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci U S A2006103166315632016606824
   PubMed Web of Science ®Google Scholar
• SunHZuYAptamers and their applications in nanomedicineSmall201511202352236425677591
   PubMedGoogle Scholar
• LiXZhaoQQiuLSmart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapyJ Control Release2013171215216223777885
   PubMed Web of Science ®Google Scholar
• JiangJChenHYuCThe promotion of salinomycin delivery to hepatocellular carcinoma cells through EGFR and CD133 aptamers conjugation by PLGA nanoparticlesNanomedicine (Lond)201510121863187926139123
   PubMed Web of Science ®Google Scholar
• SongYZhuZAnYSelection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell captureAnal Chem20138584141414923480100
   PubMed Web of Science ®Google Scholar
• PilapongCSitthichaiSThongtemSThongtemTSmart magnetic nanoparticle-aptamer probe for targeted imaging and treatment of hepatocellular carcinomaInt J Pharm20144731–246947425089503
   PubMedGoogle Scholar
• SunDLuJZhongYSensitive electrochemical aptamer cytosensor for highly specific detection of cancer cells based on the hybrid nanoelectrocatalysts and enzyme for signal amplificationBiosens Bioelectron20167530130726332382
   PubMed Web of Science ®Google Scholar
• SunDLuJChenZYuYMoMA repeatable assembling and disassembling electrochemical aptamer cytosensor for ultrasensitive and highly selective detection of human liver cancer cellsAnal Chim Acta201588516617326231902
   PubMedGoogle Scholar
• TrinhTLZhuGXiaoXA synthetic aptamer-drug adduct for targeted liver cancer therapyPLoS One20151011e013667326523833
   PubMedGoogle Scholar
• WangFBRongYFangMRecognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particlesBiomaterials201334153816382723465488
   PubMedGoogle Scholar
• MengLYangLZhaoXTargeted delivery of chemotherapy agents using a liver cancer-specific aptamerPLoS One201274e3343422558072
   PubMed Web of Science ®Google Scholar
• Tros de IlarduyaCDuzgunesNDelivery of therapeutic nucleic acids via transferrin and transferrin receptors: lipoplexes and other carriersExp Opin Drug Deliv2013101115831591
   PubMed Web of Science ®Google Scholar
• TortorellaSKaragiannisTCTransferrin receptor-mediated endocytosis: a useful target for cancer therapyJ Membrane Biol2014247429130724573305
   PubMedGoogle Scholar
• TsengHHChangJGHwangYHYehKTChenYLYuHSExpression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implicationsJ Cancer Res Clin Oncol2009135101413142019387685
   PubMed Web of Science ®Google Scholar
• HolmstromPGafvelsMErikssonLCExpression of iron regulatory genes in a rat model of hepatocellular carcinomaLiver Int200626897698516953838
   PubMed Web of Science ®Google Scholar
• MalarvizhiGLRetnakumariAPNairSKoyakuttyMTransferrin targeted core-shell nanomedicine for combinatorial delivery of doxorubicin and sorafenib against hepatocellular carcinomaNanomedicine20141081649165924905399
   PubMed Web of Science ®Google Scholar
• ZhangWPengFZhouTTargeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomesInt J Nanomedicine2015104825483626251599
   PubMed Web of Science ®Google Scholar
• RichardsonDRPonkaPThe molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cellsBiochim Biophys Acta1997133111409325434
   PubMed Web of Science ®Google Scholar
• KrishnaADMandrajuRKKishoreGKondapiAKAn efficient targeted drug delivery through apotransferrin loaded nanoparticlesPLoS One2009410e724019806207
   PubMed Web of Science ®Google Scholar
• BakerENBakerHMMolecular structure, binding properties and dynamics of lactoferrinCell Mol Life Sci200562222531253916261257
   PubMed Web of Science ®Google Scholar
• GollaKCherukuvadaBAhmedFKondapiAKEfficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in ratsPLoS One2012712e5196023284832
   PubMedGoogle Scholar
• GollaKBhaskarCAhmedFKondapiAKA target-specific oral formulation of doxorubicin-protein nanoparticles: efficacy and safety in hepatocellular cancerJ Cancer20134864465224155776
   PubMed Web of Science ®Google Scholar
• ChintharlapalliSPapineniSJutooruIMcAleesASafeSStructure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator–activated receptor γ agonists in colon cancer cellsMol Cancer Ther2007651588159817513608
   PubMedGoogle Scholar
• CaiYXuYChanHFFangXHeCChenMGlycyrrhetinic acid mediated drug delivery carriers for hepatocellular carcinoma therapyMol Pharm201613369970926808002
   PubMedGoogle Scholar
• WangFZXingLTangZHCodelivery of Doxorubicin and shAkt1 by poly(ethylenimine)-glycyrrhetinic acid nanoparticles to induce autophagy-mediated liver cancer combination therapyMol Pharm20161341298130726894988
   PubMed Web of Science ®Google Scholar
• AnirudhanTSBinusreejayanDextran based nanosized carrier for the controlled and targeted delivery of curcumin to liver cancer cellsInt J Biol Macromol20168822223527012895
   PubMed Web of Science ®Google Scholar
• NegishiMIrieANagataNIchikawaASpecific binding of glycyrrhetinic acid to the rat liver membraneBiochim Biophys Acta19911066177822065071
   PubMedGoogle Scholar
• ZengFHarrisRCEpidermal growth factor, from gene organization to bedsideSemin Cell Dev Biol20142821124513230
   PubMed Web of Science ®Google Scholar
• WolschekMFThallingerCKursaMSpecific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID miceHepatology20023651106111412395320
   PubMed Web of Science ®Google Scholar
• PrasslRLaggnerPMolecular structure of low density lipoprotein: current status and future challengesEur Biophys J200938214515818797861
   PubMedGoogle Scholar
• GoldsteinJLBrownMSThe LDL receptorArterioscler Thromb Vasc Biol200929443143819299327
   PubMed Web of Science ®Google Scholar
• BhatMSkillNMarcusVDecreased PCSK9 expression in human hepatocellular carcinomaBMC Gastroenterol20151517626674961
   PubMedGoogle Scholar
• ZhuQLZhouYGuanMLow-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapyBiomaterials201435225965597624768047
   PubMed Web of Science ®Google Scholar
• ZhangCGZhuQLZhouYN-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein for targeted osthole-loaded delivery to low-density lipoprotein receptor-rich tumorsInt J Nanomedicine201492919293224966673
   PubMed Web of Science ®Google Scholar
• WenXReynoldsLMulikRSHepatic arterial infusion of low-density lipoprotein docosahexaenoic acid nanoparticles selectively disrupts redox balance in hepatoma cells and reduces growth of orthotopic liver tumors in ratsGastroenterology2016150248849826484708
   PubMed Web of Science ®Google Scholar
• BergKSelboPKWeyergangAPorphyrin-related photosensitizers for cancer imaging and therapeutic applicationsJ Microsc2005218Pt 213314715857375
   PubMedGoogle Scholar
• ChangJEShimWSYangSGLiver cancer targeting of doxorubicin with reduced distribution to the heart using hematoporphyrin- modified albumin nanoparticles in ratsPharm Res201229379580521971829
   PubMedGoogle Scholar
• ChangJEYoonISSunPLYiEJheonSShimCKAnticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancerJ Photochem Photobiol B2014140495625090224
   PubMed Web of Science ®Google Scholar
• LackoAGNairMParanjapeSJohnsoSMcConathyWJHigh density lipoprotein complexes as delivery vehicles for anticancer drugsAnticancer Res20022242045204912174882
   PubMed Web of Science ®Google Scholar
• DamianoMGMutharasanRKTripathySMcMahonKMThaxtonCSTemplated high density lipoprotein nanoparticles as potential therapies and for molecular deliveryAdv Drug Deliv Rev201365564966222921597
   PubMed Web of Science ®Google Scholar
• DingYWangWFengMA biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapyBiomaterials201233348893890522979990
   PubMed Web of Science ®Google Scholar
• MudrakBKuehnMJHeat-labile enterotoxin: beyond G(m1) bindingToxins2010261445147022069646
   PubMedGoogle Scholar
• HardySJHolmgrenJJohanssonSSanchezJHirstTRCoordinated assembly of multisubunit proteins: oligomerization of bacterial enterotoxins in vivo and in vitroProc Natl Acad Sci U S A19888519710971133050987
   PubMedGoogle Scholar
• ZhaoLSuRCuiWShiYLiuLSuCPreparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediationInt J Nanomedicine201492149215624851048
   PubMed Web of Science ®Google Scholar
• Del RioDStewartAJMullenWHPLC-MSn analysis of phenolic compounds and purine alkaloids in green and black teaJ Agric Food Chem200452102807281515137818
   PubMed Web of Science ®Google Scholar
• LegeaySRodierMFillonLFaureSClereNEpigallocatechin gallate: a review of its beneficial properties to prevent metabolic syndromeNutrients2015775443546826198245
   PubMed Web of Science ®Google Scholar
• OzakiIYamamotoKMizutaTDifferential expression of laminin receptors in human hepatocellular carcinomaGut19984368378429824613
   PubMed Web of Science ®Google Scholar
• ZhouYYuQQinXImproving the anticancer efficacy of laminin receptor-specific therapeutic ruthenium nanoparticles (RuBB-Loaded EGCG-RuNPs) via ROS-dependent apoptosis in SMMC-7721 cellsACS Appl Mater Interfaces2015824150001501226018505
   PubMed Web of Science ®Google Scholar
• LesurtelMSollCGrafRClavienPARole of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectivesCell Mol Life Sci200865694095218080089
   PubMed Web of Science ®Google Scholar
• SollCJangJHRienerMOSerotonin promotes tumor growth in human hepatocellular cancerHepatology20105141244125420099302
   PubMed Web of Science ®Google Scholar
• SollCRienerMOOberkoflerCEExpression of serotonin receptors in human hepatocellular cancerClin Cancer Res201218215902591023087410
   PubMedGoogle Scholar
• GopalVXavierJDarGHJafurullaMChattopadhyayARaoNMTargeted liposomes to deliver DNA to cells expressing 5-HT receptorsInt J Pharm20114191–234735421855617
   PubMedGoogle Scholar
• PatelYCSomatostatin and its receptor familyFront Neuroendocrinol199920315719810433861
   PubMed Web of Science ®Google Scholar
• ReynaertHRomboutsKVandermondeAExpression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinomaGut20045381180118915247189
   PubMed Web of Science ®Google Scholar
• LambertsSWde HerderWWHoflandLJSomatostatin analogs in the diagnosis and treatment of cancerTrends Endocrinol Metab2002131045145712431842
   PubMedGoogle Scholar
• SuZNiuJXiaoYEffect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecineMol Pharm2011851641165121770405
   PubMedGoogle Scholar
• AbdellatifAAZayedGEl-BakryAZakyASaleemIYTawfeekHMNovel gold nanoparticles coated with somatostatin as a potential delivery system for targeting somatostatin receptorsDrug Dev Ind Pharm201642111782179127032509
   PubMed Web of Science ®Google Scholar
• BertrandNWuJXuXKamalyNFarokhzadOCCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biologyAdv Drug Deliv Rev20146622524270007
   PubMed Web of Science ®Google Scholar
• van der MeelRVehmeijerLJKokRJStormGvan GaalEVLigand-targeted particulate nanomedicines undergoing clinical evaluation: current statusAdv Drug Deliv Rev201365101284129824018362
   PubMed Web of Science ®Google Scholar
• CiechanoverASchwartzALLodishHFSorting and recycling of cell surface receptors and endocytosed ligands: the asialoglycoprotein and transferrin receptorsJ Cell Biochem1983231–41071306327736
   PubMed Web of Science ®Google Scholar
• KibriaGHatakeyamaHOhgaNHidaKHarashimaHDual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene deliveryJ Control Release2011153214114821447361
   PubMed Web of Science ®Google Scholar
• TakaraKHatakeyamaHKibriaGOhgaNHidaKHarashimaHSize-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapyJ Control Release2012162122523222728515
   PubMed Web of Science ®Google Scholar
• MeiLFuLShiKIncreased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEGInt J Pharm20144681–2263824709209
   PubMed Web of Science ®Google Scholar
• LiXZhouHYangLEnhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticlesBiomaterials201132102540254521232787
   PubMedGoogle Scholar
• JiangTZhangZZhangYDual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug deliveryBiomaterials201233369246925823031530
   PubMed Web of Science ®Google Scholar
• XiaoBWangXQiuZA dual-functionally modified chitosan derivative for efficient liver-targeted gene deliveryJ Biomed Mater Res A2013101A718881897
   Google Scholar
• ChenHLiMWanTDesign and synthesis of dual-ligand modified chitosan as a liver targeting vectorJ Mater Sci2012232431441
   Google Scholar
• ZhangLYaoJZhouJWangTZhangQGlycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugsInt J Pharm20134411–265466423117024
   PubMed Web of Science ®Google Scholar
• MezghraniOTangYKeXHepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicinInt J Pharm2015478255356825455765
   PubMedGoogle Scholar
• XiangHJLiuZCWangDSChenYYangYLDouKFAdenosine A(2b) receptor is highly expressed in human hepatocellular carcinomaHepatol Res2006361566016844405
   PubMedGoogle Scholar
• LiYHLiuYLiYDGABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunitWorld J Gastroenterol201218212704271122690081
   PubMedGoogle Scholar
• MaWLLaiHCYehSCaiXChangCAndrogen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitisEndocr Relat Cancer2014213R165R18224424503
   PubMed Web of Science ®Google Scholar
• BaiXWangJGuoYProstaglandin E2 stimulates beta1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-kappaB pathwaySci Rep20144653825289898
   PubMedGoogle Scholar
• ChettouhHFartouxLAoudjehaneLMitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factorsCancer Res201373133974398623633480
   PubMedGoogle Scholar
• ChunYSHuangMRinkLVon MehrenMExpression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective studyWorld J Surg Oncol20141223125052889
   PubMedGoogle Scholar
• TakayamaTSekineTMakuuchiMAdoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trialLancet2000356923280280711022927
   PubMed Web of Science ®Google Scholar
• GretenTFMannsMPKorangyFImmunotherapy of HCCRev Recent Clin Trials200831313918474013
   PubMedGoogle Scholar
• ShiLLinHLiGCisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signalsCancer Lett20163731455626805759
   PubMed Web of Science ®Google Scholar
• ChenivesseXFrancoDBréchotCMDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosisJ Hepatol19931821681728409332
   PubMedGoogle Scholar
• JinGFengGQinWTangBZLiuBLiKMultifunctional organic nanoparticles with aggregation-induced emission (AIE) characteristics for targeted photodynamic therapy and RNA interference therapyChem Commun2016521327522755
   PubMedGoogle Scholar